BioNet reports on persistence of antibody responses of recombinant pertussis vaccines in the Lancet Infectious Diseases
Publications report the sustained higher antibody responses of BioNet acellular pertussis vaccines containing genetically inactivated pertussis toxin (PTgen) and the new opportunities to control the resurgence of whooping cough disease…